Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Publications indexed to the term Uterine Cervical Neoplasms

FacultyTitle
1Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer. (Kim H, Deng W, Zamarin D, Xiao Y, Chino J, Benedict S, Nguyen H, Lowenstein J, McNulty S, Ghamande S, Ferguson C, Mell L, Holman LL, Mathews C, Quick A, Olawaiye A, Hopp E, Mannel R, Leath III CA, O'Cearbhaill RE, Aghajanian C, Schilder RJ, Mayadev J) Brachytherapy 2026;25(1):127-135       1 Citation
1Common Cancers in the Pregnant Patient. (De La Pena R, Peterson E) Obstet Gynecol Clin North Am 2025 Sep;52(3):507-517       1 Citation
1The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer. (Chino J, Erickson B, Gaffney D, Hsu IC, Kamrava M, Kim Y, Niedermayr TR, Roumeliotis M, Rownd J, Todor D, Viswanathan A, Kidd EA) Brachytherapy 2025;24(4):463-478       6 Citations
2How do you do it?: Gynecologic brachytherapy best practices at high volume institutions within the United States and Canada. (Small C, Ortiz S, Bedi M, Joyner M, Fields E, Glaser S, Erickson B) Brachytherapy 2025;24(3):365-370       2 Citations
2Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation. (Porter VL, Ng M, O'Neill K, MacLennan S, Corbett RD, Culibrk L, Hamadeh Z, Iden M, Schmidt R, Tsaih SW, Nakisige C, Origa M, Orem J, Chang G, Fan J, Nip KM, Akbari V, Chan SK, Hopkins J, Moore RA, Chuah E, Mungall KL, Mungall AJ, Birol I, Jones SJM, Rader JS, Marra MA) Genome Res 2025 Apr 14;35(4):653-670       6 Citations
1Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity Modulated Radiation Therapy for Intact Cervical Cancer: An Update. (Fields EC, Bosch WR, Albuquerque KV, Bhatia R, Chino J, Dyer B, Erickson B, Fabian D, Gaffney D, Glaser S, Han K, Hathout L, Hsu IC, Jegadeesh N, Kahn J, Kidd E, Klopp A, Leung E, Lin L, Ludwig M, Ma T, Mell L, Mayadev J, Petersen I, Portelance L, Rash D, Taunk N, Viswanathan A, Wolfson A, Yashar C, Yeung A, Yoshida E, Fisher CM) Pract Radiat Oncol 2025;15(2):171-179       6 Citations
1Dual convolution-transformer UNet (DCT-UNet) for organs at risk and clinical target volume segmentation in MRI for cervical cancer brachytherapy. (Kim G, Viswanathan AN, Bhatia R, Landman Y, Roumeliotis M, Erickson B, Schmidt EJ, Lee J) Phys Med Biol 2024 Oct 18;69(21)       6 Citations
1Postoperative urinary retention by void trial methodology following radical hysterectomy for cervical cancer. (Wagar MK, Patel UJ, Bharucha K, Heisler CA, Peterson MF, Godecker A, Wallace SK, Spencer RJ) Gynecol Oncol 2024 Nov;190:90-95       2 Citations
1Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (van den Berg MC, Berg HF, Stokowy T, Hoivik EA, Woie K, Engerud H, Ojesina AI, Haldorsen IS, Trovik J, Bertelsen BI, Krakstad C, Halle MK) Int J Gynecol Cancer 2024 Jul 01;34(7):993-1000       1 Citation
2Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study. (Kiconco A, Kabanda R, Ronald A, Beyer KMM, John SA) BMC Womens Health 2024 May 18;24(1):296       5 Citations
1Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. (Fields EC, Erickson B, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) Int J Radiat Oncol Biol Phys 2023 Dec 01;117(5):1138-1142       2 Citations
1Survival differences by race and surgical approach in early-stage operable cervical Cancer. (Summey R, Benoit M, Williams-Brown MY) Gynecol Oncol 2023 Dec;179:63-69       2 Citations
2Acceptability of Anal Human Papillomavirus Home Self-Sampling and Clinician Sampling Among Sexual and Gender Minority Individuals in Milwaukee, Wisconsin: The Prevent Anal Cancer Self-Swab Study. (Nitkowski J, Giuliano AR, Ridolfi T, Chiao E, Fernandez ME, Schick V, Swartz MD, Smith JS, Nyitray AG) LGBT Health 2024 Jan;11(1):47-56       7 Citations
2The impact of body mass index and physical disability on home-based anal self-sampling. (Nitkowski J, Fernandez ME, Ridolfi T, Chiao E, Giuliano AR, Schick V, Swartz MD, Smith JS, Nyitray AG) Cancer Causes Control 2024 Jan;35(1):161-166    
1Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy. (Jou J, Kato S, Miyashita H, Thangathurai K, Pabla S, DePietro P, Nesline MK, Conroy JM, Rubin E, Eskander RN, Kurzrock R) Mol Cancer Ther 2023 Nov 01;22(11):1352-1362       6 Citations
4A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer. (Small C, Prior P, Nasief H, Zeitlin R, Saeed H, Paulson E, Morrow N, Rownd J, Erickson B, Bedi M) Brachytherapy 2023;22(6):728-735       6 Citations
1Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer. (Mukherjee A, Ye Y, Wiener HW, Kuniholm MH, Minkoff H, Michel K, Palefsky J, D'Souza G, Rahangdale L, Butler KR, Kempf MC, Sudenga SL, Aouizerat BE, Ojesina AI, Shrestha S) Cancer Epidemiol Biomarkers Prev 2023 Sep 01;32(9):1190-1197       4 Citations
1Female reproductive health in pediatric, adolescent, and young adult cancer survivors. (Hoefgen HR, Benoit J, Chan S, Jayasinghe Y, Lustberg M, Pohl V, Saraf A, Schmidt D, Appiah LC) Pediatr Blood Cancer 2023 Sep;70 Suppl 5:e29170       5 Citations
1Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study. (Guler OC, Oymak E, Yazici G, Akagunduz OO, Cetinayak O, Erpolat P, Aksoy A, Duzova M, Yildirim BA, Kurt M, Canyilmaz E, Yavas G, Akyurek S, Oksuz DC, Saglam EK, Celik OK, Ozyar E, Cengiz M, Onal C) Oncol Res 2023;31(3):299-306       2 Citations
3Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy. (Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS) JCO Oncol Pract 2023 May;19(5):e794-e800       33 Citations
2Access to Radiation Therapy and Related Clinical Outcomes in Patients With Cervical and Breast Cancer Across Sub-Saharan Africa: A Systematic Review. (Beltrán Ponce SE, Abunike SA, Bikomeye JC, Sieracki R, Niyonzima N, Mulamira P, Kibudde S, Ortiz de Choudens S, Siker M, Small C, Beyer KMM) JCO Glob Oncol 2023 Feb;9:e2200218       14 Citations
1Cervical Cancer Screening. (Gavinski K, DiNardo D) Med Clin North Am 2023 Mar;107(2):259-269       35 Citations
1Comprehensive Review of Anal Cytology. (Hopp AM, Puzyrenko A, Giorgadze T) Acta Cytol 2023;67(2):185-194       6 Citations
1Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial. (Soler M, Alfaro K, Masch RJ, Conzuelo Rodriguez G, Qu X, Wu S, Sun J, Hernández Jovel DM, Bonilla J, Puentes LO, Murillo R, Alonzo TA, Felix JC, Castle P, Cremer M) JCO Glob Oncol 2022 Dec;8:e2200112       9 Citations
1Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy. (Massad LS, Perkins RB, Naresh A, Nelson EL, Spiryda L, Gecsi KS, Mulhem E, Kostas-Polston E, Zou T, Giles TL, Wentzensen N) J Low Genit Tract Dis 2023 Jan 01;27(1):97-101       41 Citations
1GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina. (Kamrava M, Leung E, Bachand F, Beriwal S, Chargari C, D'Souza D, Erickson B, Fokdal L, Han K, Harkenrider M, Lin L, Mahantshetty U, Nesvacil N, Ravi A, Schmid M, Vigneault E, Westerveld H, Yashar C, Nout R) Int J Radiat Oncol Biol Phys 2023 Mar 01;115(3):654-663       29 Citations
1Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer. (Parashar D, Singh A, Gupta S, Sharma A, Sharma MK, Roy KK, Chauhan SC, Kashyap VK) Genes (Basel) 2022 Jul 15;13(7)       29 Citations
1The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy. (Onal C, Gultekin M, Yavas G, Oymak E, Yuce Sari S, Guler OC, Yigit E, Yildiz F) J Obstet Gynaecol 2022 Aug;42(6):2426-2432       8 Citations
1High-resolution disease maps for cancer control in low-resource settings: A spatial analysis of cervical cancer incidence in Kampala, Uganda. (Beyer K, Kasasa S, Anguzu R, Lukande R, Nambooze S, Amulen PM, Zhou Y, Nansereko B, Jankowski C, Oyana T, Savino D, Feustel K, Wabinga H) J Glob Health 2022;12:04032       7 Citations
2Dosimetric predictors of local control and complications in gynecologic transperineal implant patients: The medical college of wisconsin experience. (Zeitlin R, Yu G, Wheatley M, Morrow N, Rownd J, Rein L, Banerjee A, Bedi M, Erickson B) Brachytherapy 2022;21(1):94-109       3 Citations
1Longitudinal Outcomes from Conservative Management of Cervical Cancer Associated Ureteral Obstruction. (Botkin HE, Faidley KN, Loeffler BT, Mott SL, Hill EK, Erickson BA) Urology 2021 Dec;158:208-214       4 Citations
2Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes. (Iden M, Tsaih SW, Huang YW, Liu P, Xiao M, Flister MJ, Rader JS) Br J Cancer 2021 Nov;125(10):1408-1419       19 Citations
1Rural-urban differences in HPV testing for cervical cancer screening. (Locklar LRB, Do DP) J Rural Health 2022 Mar;38(2):409-415       19 Citations
1Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al. (Onal C, Yavas G, Yavas C) Strahlenther Onkol 2021 Oct;197(10):935-936    
1Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California. (Lonky NM, Xu L, Da Silva DM, Felix JC, Chao C) Am J Obstet Gynecol 2021 Dec;225(6):656.e1-656.e11       1 Citation
1MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers. (Nejati K, Alivand M, Arabzadeh A) Pathol Res Pract 2021 Jul;223:153452       26 Citations
1Maternal to fetal transmission of cancer: implications for molecular tumor testing, immune regulation, and pediatric malignancies. (Eskander RN, Kurzrock R) Med 2021 Mar 12;2(3):211-213       1 Citation
1Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. (Coleman RL, Lorusso D, Gennigens C, González-Martín A, Randall L, Cibula D, Lund B, Woelber L, Pignata S, Forget F, Redondo A, Vindeløv SD, Chen M, Harris JR, Smith M, Nicacio LV, Teng MSL, Laenen A, Rangwala R, Manso L, Mirza M, Monk BJ, Vergote I, innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators) Lancet Oncol 2021 May;22(5):609-619       374 Citations
1A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (Halle MK, Sødal M, Forsse D, Engerud H, Woie K, Lura NG, Wagner-Larsen KS, Trovik J, Bertelsen BI, Haldorsen IS, Ojesina AI, Krakstad C) Br J Cancer 2021 May;124(10):1690-1698       25 Citations
1Is the age of cervical cancer diagnosis changing over time? (Gnade CM, Hill EK, Botkin HE, Hefel AR, Hansen HE, Sheets KA, Mott SL, Hardy-Fairbanks AJ, Stockdale CK) J Gynecol Obstet Hum Reprod 2021 Sep;50(7):102040       13 Citations
1Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador. (Alfaro K, Maza M, Felix JC, Gage JC, Castle PE, Alonzo TA, Chacón A, González E, Soler M, Conzuelo-Rodriguez G, Masch R, Cremer M) JCO Glob Oncol 2020 Oct;6:1519-1530       18 Citations
1The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes. (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch J, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Gynecol Oncol 2020 Dec;159(3):607-610       35 Citations
1NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. (Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK) Int J Radiat Oncol Biol Phys 2021 Feb 01;109(2):413-424       127 Citations
1Effect of Obesity on Cervical Cancer Screening and Outcomes. (Gnade CM, Hill EK, Botkin HE, Hefel AR, Hansen HE, Sheets KA, Mott SL, Hardy-Fairbanks AJ, Stockdale CK) J Low Genit Tract Dis 2020 Oct;24(4):358-362       23 Citations
1HPV-EM: an accurate HPV detection and genotyping EM algorithm. (Inkman MJ, Jayachandran K, Ellis TM, Ruiz F, McLellan MD, Miller CA, Wu Y, Ojesina AI, Schwarz JK, Zhang J) Sci Rep 2020 Aug 31;10(1):14340       8 Citations
1Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017. (Deshmukh AA, Suk R, Shiels MS, Damgacioglu H, Lin YY, Stier EA, Nyitray AG, Chiao EY, Nemutlu GS, Chhatwal J, Schmeler K, Sigel K, Sonawane K) J Natl Cancer Inst 2021 Jun 01;113(6):792-796       60 Citations
2Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. (Gagliardi A, Porter VL, Zong Z, Bowlby R, Titmuss E, Namirembe C, Griner NB, Petrello H, Bowen J, Chan SK, Culibrk L, Darragh TM, Stoler MH, Wright TC, Gesuwan P, Dyer MA, Ma Y, Mungall KL, Jones SJM, Nakisige C, Novik K, Orem J, Origa M, Gastier-Foster JM, Yarchoan R, Casper C, Mills GB, Rader JS, Ojesina AI, Gerhard DS, Mungall AJ, Marra MA) Nat Genet 2020 Aug;52(8):800-810       59 Citations
1Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model. (Alson D, Schuyler SC, Yan BX, Samimuthu K, Qiu JT) Front Immunol 2020;11:927       9 Citations
1Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Pract Radiat Oncol 2020;10(4):220-234       221 Citations
1Updates in Cervical Cancer Treatment. (Hill EK) Clin Obstet Gynecol 2020 Mar;63(1):3-11       67 Citations
1The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. (Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim JJ) Prev Med 2020 Feb;131:105931       13 Citations
2Identification and validation of a prognostic proteomic signature for cervical cancer. (Rader JS, Pan A, Corbin B, Iden M, Lu Y, Vellano CP, Akbani R, Mills GB, Simpson P) Gynecol Oncol 2019 Nov;155(2):324-330       7 Citations
1NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy. (Chen H, Zeng X, Tham HP, Phua SZF, Cheng W, Zeng W, Shi H, Mei L, Zhao Y) Angew Chem Int Ed Engl 2019 Jun 03;58(23):7641-7646       161 Citations
1Management of Nodal Disease in Advanced Cervical Cancer. (Jürgenliemk-Schulz IM, Beriwal S, de Leeuw AAC, Lindegaard JC, Nomden CN, Pötter R, Tanderup K, Viswanathan AN, Erickson B) Semin Radiat Oncol 2019 Apr;29(2):158-165       38 Citations
1The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador. (Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ) Int J Gynaecol Obstet 2019 Apr;145(1):40-46       24 Citations
1Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study. (Lazcano-Ponce E, Salmerón J, González A, Allen-Leigh B, León-Maldonado L, Magis C, Aranda-Flores C, Conde-González C, Portillo-Romero AJ, Yunes-Díaz E, Rivera-Rivera L, Vargas G, Nyitray AG, Giuliano AR) Salud Publica Mex 2018;60(6):703-712       12 Citations
1Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer. (Yavas G, Yavas C, Sen E, Oner I, Celik C, Ata O) Int J Gynecol Cancer 2019 Jan;29(1):42-47       31 Citations
1Response to "Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?". (McGregor A, Gecsi K) J Low Genit Tract Dis 2019 Jan;23(1):85    
3Genetic variations in human papillomavirus and cervical cancer outcomes. (Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ) Int J Cancer 2019 May 01;144(9):2206-2214       36 Citations
1HLA and KIR Associations of Cervical Neoplasia. (Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ) J Infect Dis 2018 Nov 05;218(12):2006-2015       27 Citations
1Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador. (Maza M, Melendez M, Masch R, Alfaro K, Chacon A, Gonzalez E, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M) Prev Med 2018 Sep;114:149-155       33 Citations
1Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen. (Spurgeon ME, den Boon JA, Horswill M, Barthakur S, Forouzan O, Rader JS, Beebe DJ, Roopra A, Ahlquist P, Lambert PF) Proc Natl Acad Sci U S A 2017 Oct 24;114(43):E9076-E9085       69 Citations
1Pelvic radiotherapy does not deteriorate the quality of life of women with gynecologic cancers in long-term follow-up: A 2 years prospective single-center study. (Yavas G, Yavas C, Dogan NU, Ilhan TT, Dogan S, Karabagli P, Ata O, Yuce E, Celik C) J Cancer Res Ther 2017;13(3):524-532       12 Citations
3Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer. (Palatnik A, Ye S, Kendziorski C, Iden M, Zigman JS, Hessner MJ, Rader JS) PLoS One 2017;12(8):e0181242       10 Citations
1Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. (Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA) PLoS Genet 2017 Aug;13(8):e1006866       98 Citations
1Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. (Halle MK, Ojesina AI, Engerud H, Woie K, Tangen IL, Holst F, Høivik E, Kusonmano K, Haldorsen IS, Vintermyr OK, Trovik J, Bertelsen BI, Salvesen HB, Krakstad C) Am J Obstet Gynecol 2017 Oct;217(4):432.e1-432.e17       47 Citations
1Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. (Sharabi A, Kim SS, Kato S, Sanders PD, Patel SP, Sanghvi P, Weihe E, Kurzrock R) Oncologist 2017 Jun;22(6):631-637       100 Citations
2The Unique Issues With Brachytherapy in Low- and Middle-Income Countries. (Grover S, Longo J, Einck J, Puri P, Brown D, Chino J, Mahantshetty U, Yashar C, Erickson B) Semin Radiat Oncol 2017 Apr;27(2):136-142       41 Citations
1A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. (Rader JS, Sill MW, Beumer JH, Lankes HA, Benbrook DM, Garcia F, Trimble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA 3rd, Spirtos NM, Byron J, Thaker PH, Lele S, Alberts D) Gynecol Oncol 2017 May;145(2):291-297       21 Citations
4Integrated genomic and molecular characterization of cervical cancer. (Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, Analytical Biological Services, Barretos Cancer Hospital, Baylor College of Medicine, Beckman Research Institute of City of Hope, Buck Institute for Research on Aging, Canada's Michael Smith Genome Sciences Centre, Harvard Medical School, Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services, HudsonAlpha Institute for Biotechnology, ILSbio, LLC, Indiana University School of Medicine, Institute of Human Virology, Institute for Systems Biology, International Genomics Consortium, Leidos Biomedical, Massachusetts General Hospital, McDonnell Genome Institute at Washington University, Medical College of Wisconsin, Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, NantOmics, National Cancer Institute, National Hospital, Abuja, Nigeria, National Human Genome Research Institute, National Institute of Environmental Health Sciences, National Institute on Deafness &Other Communication Disorders, Ontario Tumour Bank, London Health Sciences Centre, Ontario Tumour Bank, Ontario Institute for Cancer Research, Ontario Tumour Bank, The Ottawa Hospital, Oregon Health &Science University, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, SRA International, St Joseph's Candler Health System, Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University, Research Institute at Nationwide Children's Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of Bergen, University of Texas MD Anderson Cancer Center, University of Abuja Teaching Hospital, University of Alabama at Birmingham, University of California, Irvine, University of California Santa Cruz, University of Kansas Medical Center, University of Lausanne, University of New Mexico Health Sciences Center, University of North Carolina at Chapel Hill, University of Oklahoma Health Sciences Center, University of Pittsburgh, University of São Paulo, Ribeir ão Preto Medical School, University of Southern California, University of Washington, University of Wisconsin School of Medicine &Public Health, Van Andel Research Institute, Washington University in St Louis) Nature 2017 Mar 16;543(7645):378-384       1241 Citations
1American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer. (Mayadev J, Viswanathan A, Liu Y, Li CS, Albuquerque K, Damato AL, Beriwal S, Erickson B) Brachytherapy 2017;16(1):22-43       39 Citations
1The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. (Viswanathan AN, Erickson BA, Ibbott GS, Small W Jr, Eifel PJ) Brachytherapy 2017;16(1):68-74       12 Citations
2Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression. (Liu P, Iden M, Fye S, Huang YW, Hopp E, Chu C, Lu Y, Rader JS) Cancer Epidemiol Biomarkers Prev 2017 Apr;26(4):642-650       23 Citations
1American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. (Suneja G, Brown D, Chang A, Erickson B, Fidarova E, Grover S, Mahantshetty U, Nag S, Narayan K, Bvochora-Nsingo M, Viegas C, Viswanathan AN, Lin MY, Gaffney D) Brachytherapy 2017;16(1):85-94       53 Citations
1Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador. (Cremer M, Maza M, Alfaro K, Morales Velado M, Felix J, Castle PE, Kim J, Gage JC) J Low Genit Tract Dis 2017 Jan;21(1):26-32       26 Citations
1Cervical cancer screening: How our approach may change. (Hofmeister S) J Fam Pract 2016 Aug;65(8):551-3       1 Citation
2The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis. (Iden M, Fye S, Li K, Chowdhury T, Ramchandran R, Rader JS) PLoS One 2016;11(5):e0156274       146 Citations
1mRNA-based hrHPV assay in cotesting for cervical cancer screening. (Felix J) MLO Med Lab Obs 2016 Apr;48(4):22-3    
1The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis. (Felix JC, Lacey MJ, Miller JD, Lenhart GM, Spitzer M, Kulkarni R) J Womens Health (Larchmt) 2016 Jun;25(6):606-16       34 Citations
1Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador. (Cremer ML, Maza M, Alfaro KM, Kim JJ, Ditzian LR, Villalta S, Alonzo TA, Felix JC, Castle PE, Gage JC) J Low Genit Tract Dis 2016 Apr;20(2):145-50       21 Citations
1Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society. (Grover S, Harkenrider MM, Cho LP, Erickson B, Small C, Small W Jr, Viswanathan AN) Int J Radiat Oncol Biol Phys 2016 Mar 01;94(3):598-604       114 Citations
1Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program. (Alfaro KM, Gage JC, Rosenbaum AJ, Ditzian LR, Maza M, Scarinci IC, Miranda E, Villalta S, Felix JC, Castle PE, Cremer ML) BMC Public Health 2015 Oct 16;15:1058       20 Citations
1Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. (Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A) Pract Radiat Oncol 2015;5(6):e557-65       8 Citations
1Lymph Node Micrometastases in Early-Stage Cervical Cancer are Not Predictive of Survival. (Stany MP, Stone PJ, Felix JC, Amezcua CA, Groshen S, Ye W, Kyser KL, Howard RS, Zahn CM, Muderspach LI, Lentz SE, Chernofsky MR) Int J Gynecol Pathol 2015 Jul;34(4):379-84       20 Citations
1Evolving traditions on the technology journey. (Erickson B) Int J Radiat Oncol Biol Phys 2015 Jan 01;91(1):14-6       1 Citation
1Response to Yasri, "Associations between religion-related factors and cervical cancer screening among Muslims in Greater Chicago." J Low Genit Tract Dis. 2014 June 9. [E-pub ahead of print]. (Padela AI) J Low Genit Tract Dis 2015 Apr;19(2):e45    
1Brachytherapy: where has it gone? (Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, Wazer DE) J Clin Oncol 2015 Mar 20;33(9):980-2       113 Citations
1The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. (Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Cremer ML, Kim JJ) Int J Cancer 2015 Aug 15;137(4):893-902       41 Citations
1Mobile fiber-optic sensor for detection of oral and cervical cancer in the developing world. (Yu B, Nagarajan VK, Ferris DG) Methods Mol Biol 2015;1256:155-70       1 Citation
1Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. (Chung TK, Van Hummelen P, Chan PK, Cheung TH, Yim SF, Yu MY, Ducar MD, Thorner AR, MacConaill LE, Doran G, Pedamallu CS, Ojesina AI, Wong RR, Wang VW, Freeman SS, Lau TS, Kwong J, Chan LK, Fromer M, May T, Worley MJ Jr, Esselen KM, Elias KM, Lawrence M, Getz G, Smith DI, Crum CP, Meyerson M, Berkowitz RS, Wong YF) Int J Cancer 2015 Aug 15;137(4):776-83       45 Citations
1Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience. (Hou MM, Liu X, Wheler J, Naing A, Hong D, Coleman RL, Tsimberidou A, Janku F, Zinner R, Lu K, Kurzrock R, Fu S) Oncotarget 2014 Nov 30;5(22):11168-79       58 Citations
1Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. (Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W) Int J Radiat Oncol Biol Phys 2014 Oct 01;90(2):320-8       179 Citations
1Polymorphisms in immune mediators associate with risk of cervical cancer. (Zhang Z, Fye S, Borecki IB, Rader JS) Gynecol Oncol 2014 Oct;135(1):69-73       15 Citations
1EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. (Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S) Int J Cancer 2015 Jun 15;136(12):2752-60       256 Citations
1Associations between religion-related factors and cervical cancer screening among Muslims in greater chicago. (Padela AI, Peek M, Johnson-Agbakwu CE, Hosseinian Z, Curlin F) J Low Genit Tract Dis 2014 Oct;18(4):326-32       76 Citations
1Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. (Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC, Felix JC, Castle PE, Villalta S, Miranda E, Cremer ML) Int J Gynaecol Obstet 2014 Aug;126(2):156-60       57 Citations
73-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes. (Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B) Brachytherapy 2014;13(4):319-25       30 Citations
1Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program. (Hou MM, Liu X, Wheler J, Naing A, Hong D, Bodurka D, Schmeler K, Tsimberidou A, Janku F, Zinner R, Piha-Paul S, Hu CY, Lu K, Kurzrock R, Fu S) Anticancer Res 2014 May;34(5):2349-55       7 Citations
1Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus. (Piha-Paul SA, Wheler JJ, Fu S, Levenback C, Lu K, Falchook GS, Naing A, Hong DS, Tsimberidou AM, Kurzrock R) Oncotarget 2014 Apr 15;5(7):1846-55       34 Citations
1AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake. (Rashmi R, DeSelm C, Helms C, Bowcock A, Rogers BE, Rader JL, Rader J, Grigsby PW, Schwarz JK) PLoS One 2014;9(4):e92948       80 Citations
1HER2 aberrations in cancer: implications for therapy. (Yan M, Parker BA, Schwab R, Kurzrock R) Cancer Treat Rev 2014 Jul;40(6):770-80       202 Citations
2Hypermethylation of miR-203 in endometrial carcinomas. (Huang YW, Kuo CT, Chen JH, Goodfellow PJ, Huang TH, Rader JS, Uyar DS) Gynecol Oncol 2014 May;133(2):340-5       52 Citations
1Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study. (Eifel PJ, Ho A, Khalid N, Erickson B, Owen J) Int J Radiat Oncol Biol Phys 2014 Jun 01;89(2):249-56       82 Citations
1Landscape of genomic alterations in cervical carcinomas. (Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Treviño V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabiño NB, Gómez-Macías GS, Valdez-Chapa LD, Garza-Rodríguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldaña HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M) Nature 2014 Feb 20;506(7488):371-5       752 Citations
1Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. (Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD) Am J Obstet Gynecol 2014 Apr;210(4):366.e1-366.e5       30 Citations
2Genomics of cervical cancer and the role of human papillomavirus pathobiology. (Uyar D, Rader J) Clin Chem 2014 Jan;60(1):144-6       48 Citations
1Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer. (Ma D, Hovey RL, Zhang Z, Fye S, Huettner PC, Borecki IB, Rader JS) Gynecol Oncol 2013 Nov;131(2):445-50       10 Citations
1Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo. (Saini S, Agarwal S, Sinha A, Verma A, Parashar D, Gupta N, Ansari AS, Lohiya NK, Jagadish N, Suri A) Cancer Gene Ther 2013 Jul;20(7):413-20       22 Citations
1Patient barriers to follow-up care for breast and cervical cancer abnormalities. (Tejeda S, Darnell JS, Cho YI, Stolley MR, Markossian TW, Calhoun EA) J Womens Health (Larchmt) 2013 Jun;22(6):507-17       73 Citations
1Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. (Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, Powell MA, Thaker PH, Eisenhauer EL, Cohn DE, Valea FA, Alvarez Secord A, Lippmann LT, Dehdashti F, Rader JS) Gynecol Oncol 2013 Jul;130(1):64-8       78 Citations
1Expression and humoral response of A-kinase anchor protein 4 in cervical cancer. (Agarwal S, Saini S, Parashar D, Verma A, Jagadish N, Batra A, Suri S, Bhatnagar A, Gupta A, Ansari AS, Lohiya NK, Suri A) Int J Gynecol Cancer 2013 May;23(4):650-8       22 Citations
1ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer. (Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK) Am J Clin Oncol 2012 Aug;35(4):399-405       16 Citations
1Prospective assessment of quality of life and psychological distress in patients with gynecologic malignancy: a 1-year prospective study. (Yavas G, Dogan NU, Yavas C, Benzer N, Yuce D, Celik C) Int J Gynecol Cancer 2012 Jul;22(6):1096-101       24 Citations
1Comment on "Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study" by Ferrandina et al. (GYNECOL ONCOL 2012; 124:389-394). (Yavas G, Yavas C) Gynecol Oncol 2012 Jul;126(1):167; author reply 167-8       1 Citation
1PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. (Janku F, Wheler JJ, Westin SN, Moulder SL, Naing A, Tsimberidou AM, Fu S, Falchook GS, Hong DS, Garrido-Laguna I, Luthra R, Lee JJ, Lu KH, Kurzrock R) J Clin Oncol 2012 Mar 10;30(8):777-82       416 Citations
1American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. (Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B, American Brachytherapy Society) Brachytherapy 2012;11(1):47-52       506 Citations
1Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. (Schwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, Rogers BE, Yang Q, Watson M, Rader JS, Grigsby PW) Clin Cancer Res 2012 Mar 01;18(5):1464-71       99 Citations
1The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. (Viswanathan AN, Moughan J, Small W Jr, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK) Int J Gynecol Cancer 2012 Jan;22(1):123-31       122 Citations
1Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. (Dehner LP, Jarzembowski JA, Hill DA) Mod Pathol 2012 Apr;25(4):602-14       143 Citations
1ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. (Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR, American College of Radiology (ACR)) Gynecol Oncol 2012 Apr;125(1):256-62       15 Citations
1Towards a field-compatible optical spectroscopic device for cervical cancer screening in resource-limited settings: effects of calibration and pressure. (Chang VT, Merisier D, Yu B, Walmer DK, Ramanujam N) Opt Express 2011 Sep 12;19(19):17908-24       17 Citations
1Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K) Int J Gynecol Cancer 2011 Oct;21(7):1266-75       40 Citations
1Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response? (Siegel EM, Patel N, Lu B, Lee JH, Nyitray AG, Craft NE, Frenkel K, Villa LL, Franco EL, Giuliano AR) Int J Cancer 2012 Jul 01;131(1):219-28       9 Citations
1Perceived need of a parental decision aid for the HPV vaccine: content and format preferences. (Lechuga J, Swain G, Weinhardt LS) Health Promot Pract 2012 Mar;13(2):214-21       18 Citations
1HPV vaccination to prevent HIV infection: time for randomized controlled trials. (van der Loeff MF, Nyitray AG, Giuliano AR) Sex Transm Dis 2011 Jul;38(7):640-3       17 Citations
1ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology. (Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Int J Radiat Oncol Biol Phys 2011 Nov 01;81(3):609-14       71 Citations
1Male circumcision and HPV transmission to female partners. (Giuliano AR, Nyitray AG, Albero G) Lancet 2011 Jan 15;377(9761):183-4       7 Citations
1Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. (Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA) Obstet Gynecol 2010 Nov;116(5):1150-7       47 Citations
1The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. (Kizer NT, Thaker PH, Gao F, Zighelboim I, Powell MA, Rader JS, Mutch DG, Grigsby PW) Cancer 2011 Mar 01;117(5):948-56       87 Citations
1HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. (Martin MP, Borecki IB, Zhang Z, Nguyen L, Ma D, Gao X, Qi Y, Carrington M, Rader JS) Immunogenetics 2010 Dec;62(11-12):761-5       32 Citations
1Evaluation of the clinical performance of high-risk human papillomavirus testing for primary screening: a retrospective review of the Southern California Permanente Medical Group experience. (Lonky NM, Mahdavi A, Wolde-Tsadik G, Bajamundi K, Felix JC) J Low Genit Tract Dis 2010 Jul;14(3):200-5       1 Citation
2The relationship of health numeracy to cancer screening. (Schapira MM, Neuner J, Fletcher KE, Gilligan MA, Hayes E, Laud P) J Cancer Educ 2011 Mar;26(1):103-10       17 Citations
1Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. (Lim K, Small W Jr, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, Gyn IMRT Consortium) Int J Radiat Oncol Biol Phys 2011 Feb 01;79(2):348-55       414 Citations
1Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. (Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW) J Clin Oncol 2010 Apr 20;28(12):2108-13       275 Citations
1TP53, MDM2, NQO1, and susceptibility to cervical cancer. (Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS) Cancer Epidemiol Biomarkers Prev 2010 Mar;19(3):755-61       55 Citations
1A microRNA expression signature for cervical cancer prognosis. (Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X) Cancer Res 2010 Feb 15;70(4):1441-8       281 Citations
1Recent advances in the surgical management of cervical cancer. (Zakashansky K, Bradley WH, Chuang L, Rahaman J, Dottino P) Mt Sinai J Med 2009 Dec;76(6):567-76       14 Citations
118F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer. (Showalter TN, Miller TR, Huettner P, Rader J, Grigsby PW) Int J Gynecol Cancer 2009 Nov;19(8):1412-4       33 Citations
1Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer. (Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS) Gynecol Oncol 2010 Mar;116(3):539-43       35 Citations
1Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. (Qian N, Chen X, Han S, Qiang F, Jin G, Zhou X, Dong J, Wang X, Shen H, Hu Z) J Cancer Res Clin Oncol 2010 May;136(5):709-16       57 Citations
1Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. (Nugent EK, Case AS, Hoff JT, Zighelboim I, DeWitt LL, Trinkhaus K, Mutch DG, Thaker PH, Massad LS, Rader JS) Gynecol Oncol 2010 Mar;116(3):438-41       63 Citations
1Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. (Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutic S, Mutch DG, Powell MA, Grigsby PW) Int J Radiat Oncol Biol Phys 2010 Jul 15;77(4):1085-91       184 Citations
1Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. (Viswanathan AN, Erickson BA) Int J Radiat Oncol Biol Phys 2010 Jan 01;76(1):104-9       184 Citations
1HPV screening for cervical cancer in rural India. (Cremer ML, Conlisk E, Felix JC) N Engl J Med 2009 Jul 16;361(3):305; author reply 306       5 Citations
1The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. (Massad LS, Jeronimo J, Katki HA, Schiffman M, National Institutes of Health/American Society for Colposcopy and Cervical Pathology Research Group) J Low Genit Tract Dis 2009 Jul;13(3):137-44       140 Citations
1Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis. (Zhou X, Han S, Wang S, Chen X, Dong J, Shi X, Xia Y, Wang X, Hu Z, Shen H) Gynecol Oncol 2009 Aug;114(2):327-31       30 Citations
1Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake. (Kidd EA, Spencer CR, Huettner PC, Siegel BA, Dehdashti F, Rader JS, Grigsby PW) Cancer 2009 Aug 01;115(15):3548-54       79 Citations
1CD83 polymorphisms and cervical cancer risk. (Yu KJ, Rader JS, Borecki I, Zhang Z, Hildesheim A) Gynecol Oncol 2009 Aug;114(2):319-22       20 Citations
1Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. (Brooks RA, Wright JD, Powell MA, Rader JS, Gao F, Mutch DG, Wall LL) Gynecol Oncol 2009 Jul;114(1):75-9       47 Citations
1Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. (Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, Shen H, Hu Z) Clin Cancer Res 2009 Jan 01;15(1):400-5       90 Citations
1Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. (Brooks RA, Rader JS, Dehdashti F, Mutch DG, Powell MA, Thaker PH, Siegel BA, Grigsby PW) Gynecol Oncol 2009 Jan;112(1):104-9       95 Citations
1Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. (Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM) PLoS One 2008 Jul 02;3(7):e2557       667 Citations
1Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. (Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, Cho KR, Bonfiglio TA, Nayar R, Plass C, Sherman ME) Cancer Res 2008 Apr 01;68(7):2489-97       58 Citations
1New techniques in radical hysterectomy. (Zakashansky K, Bradley WH, Nezhat FR) Curr Opin Obstet Gynecol 2008 Feb;20(1):14-9       32 Citations
1CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. (Zhang Z, Borecki I, Nguyen L, Ma D, Smith K, Huettner PC, Mutch DG, Herzog TJ, Gibb RK, Powell MA, Grigsby PW, Massad LS, Hernandez E, Judson PL, Swisher EM, Crowder S, Li J, Gerhard DS, Rader JS) Cancer Res 2007 Dec 01;67(23):11202-8       32 Citations
1Evaluation of candidate methylation markers to detect cervical neoplasia. (Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS) Gynecol Oncol 2007 Dec;107(3):549-53       58 Citations
1Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer. (Wright JD, Grigsby PW, Rader JS, Mutch DG, Powell MA, Gao F, Gibb RK) Gynecol Oncol 2007 Nov;107(2):280-4       3 Citations
1Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. (Gius D, Funk MC, Chuang EY, Feng S, Huettner PC, Nguyen L, Bradbury CM, Mishra M, Gao S, Buttin BM, Cohn DE, Powell MA, Horowitz NS, Whitcomb BP, Rader JS) Cancer Res 2007 Aug 01;67(15):7113-23       79 Citations
1Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. (Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, Rader JS, Mutch DG) Cancer 2007 Sep 15;110(6):1281-6       202 Citations
1A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. (Roman LD, Wilczynski S, Muderspach LI, Burnett AF, O'Meara A, Brinkman JA, Kast WM, Facio G, Felix JC, Aldana M, Weber JS) Gynecol Oncol 2007 Sep;106(3):558-66       105 Citations
1Diagnosing cervical biopsies in adolescents: the use of p16 immunohistochemistry to improve reliability and reproducibility. (Sayed K, Korourian S, Ellison DA, Kozlowski K, Talley L, Horn HV, Simpson P, Parham DM) J Low Genit Tract Dis 2007 Jul;11(3):141-6       19 Citations
1Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K) Int J Radiat Oncol Biol Phys 2007 Jul 15;68(4):1081-7       129 Citations
1Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. (Zighelboim I, Taylor NP, Powell MA, Gibb RK, Rader JS, Mutch DG, Grigsby PW) Radiat Med 2006 Nov;24(9):625-30       38 Citations
1Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists. (Society of Gynecologic Oncologists Education Resource Panel Writing group, Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, Rader JS, Wright J) Gynecol Oncol 2006 Sep;102(3):552-62       43 Citations
1Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation. (Wang SS, Sherman ME, Rader JS, Carreon J, Schiffman M, Baker CC) Diagn Mol Pathol 2006 Sep;15(3):144-8       37 Citations
1Colposcopic accuracy of obstetrics and gynecology residents. (Baum ME, Rader JS, Gibb RK, McAlister RP, Powell MA, Mutch DG, Gao F, Wright JD) Gynecol Oncol 2006 Dec;103(3):966-70       42 Citations
1Gene expression patterns in advanced human cervical cancer. (Grigsby PW, Watson M, Powell MA, Zhang Z, Rader JS) Int J Gynecol Cancer 2006;16(2):562-7       28 Citations
1Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data. (Fitzpatrick MA, Funk MC, Gius D, Huettner PC, Zhang Z, Bidder M, Ma D, Powell MA, Rader JS) Gynecol Oncol 2006 Nov;103(2):458-62       18 Citations
1Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer. (Wright JD, Viviano D, Powell MA, Gibb RK, Mutch DG, Grigsby PW, Rader JS) Gynecol Oncol 2006 Nov;103(2):489-93       100 Citations
1Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. (Zhang Z, Huettner PC, Nguyen L, Bidder M, Funk MC, Li J, Rader JS) Oncogene 2006 Aug 31;25(39):5436-45       34 Citations
1Human papillomavirus triage for young women with atypical squamous cells of undetermined significance. (Wright JD, Rader JS, Davila R, Powell MA, Mutch DG, Gao F, Gibb RK) Obstet Gynecol 2006 Apr;107(4):822-9       23 Citations
2Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. (Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, Dumas I, Erickson B, Lang S, Nulens A, Petrow P, Rownd J, Kirisits C, GEC ESTRO Working Group) Radiother Oncol 2006 Jan;78(1):67-77       1562 Citations
1Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. (Wright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS, Gibb RK, Powell MA, Gao F, Siegel BA, Grigsby PW) Cancer 2005 Dec 01;104(11):2484-91       158 Citations
1Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. (Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman LD) Gynecol Oncol 2006 Feb;100(2):288-93       58 Citations
2Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study. (Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J) Int J Radiat Oncol Biol Phys 2005 Nov 15;63(4):1083-92       68 Citations
1Tumor-associated alterations in caspase-14 expression in epithelial malignancies. (Krajewska M, Kim H, Shin E, Kennedy S, Duffy MJ, Wong YF, Marr D, Mikolajczyk J, Shabaik A, Meinhold-Heerlein I, Huang X, Banares S, Hedayat H, Reed JC, Krajewski S) Clin Cancer Res 2005 Aug 01;11(15):5462-71       63 Citations
1Cervical sarcomas: an analysis of incidence and outcome. (Wright JD, Rosenblum K, Huettner PC, Mutch DG, Rader JS, Powell MA, Gibb RK) Gynecol Oncol 2005 Nov;99(2):348-51       63 Citations
1Digital camera assessment for detection of cervical intraepithelial neoplasia in rural El Salvador. (Cremer M, Jamshidi RM, Muderspach L, Tsao-Wei D, Felix JC, Blumenthal PD) Int J Gynaecol Obstet 2005 Oct;91(1):42-6       18 Citations
1Cervical dysplasia in adolescents. (Wright JD, Davila RM, Pinto KR, Merritt DF, Gibb RK, Rader JS, Mutch DG, Gao F, Powell MA) Obstet Gynecol 2005 Jul;106(1):115-20       65 Citations
1Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma. (Wright JD, Li J, Gerhard DS, Zhang Z, Huettner PC, Powell MA, Gibb RK, Herzog TJ, Mutch DG, Trinkaus KM, Rader JS) Gynecol Oncol 2005 Jul;98(1):84-91       28 Citations
2Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). (Pötter R, Dimopoulos J, Kirisits C, Lang S, Haie-Meder C, Briot E, Dumas I, Van Limbergen E, De Brabandere M, Nulens A, Erickson B, Rownd J, Petrow P) Int J Radiat Oncol Biol Phys 2005 May 01;62(1):293-5; author reply 295-6       30 Citations
1Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. (Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS) Genes Chromosomes Cancer 2005 May;43(1):95-103       15 Citations
1Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. (Grigsby PW, Mutch DG, Rader J, Herzog TJ, Zoberi I, Siegel BA, Dehdashti F) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):444-9       31 Citations
1Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. (Singh AK, Grigsby PW, Rader JS, Mutch DG, Powell MA) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):450-5       71 Citations
1IGSF4 promoter methylation and expression silencing in human cervical cancer. (Li J, Zhang Z, Bidder M, Funk MC, Nguyen L, Goodfellow PJ, Rader JS) Gynecol Oncol 2005 Jan;96(1):150-8       37 Citations
1Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. (Wright JD, Gibb RK, Geevarghese S, Powell MA, Herzog TJ, Mutch DG, Grigsby PW, Gao F, Trinkaus KM, Rader JS) Cancer 2005 Jan 01;103(1):85-91       83 Citations
1Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. (Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1144-53       122 Citations
1Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. (Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M, Image-Guided Brachytherapy Working Group) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1160-72       205 Citations
1A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? (Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS) Gynecol Oncol 2004 Oct;95(1):70-6       56 Citations
1Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? (Kamelle SA, Rutledge TL, Tillmanns TD, Gould NS, Cohn DE, Wright J, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS) Gynecol Oncol 2004 Aug;94(2):249-55       31 Citations
1False positive diagnosis in conventional and liquid-based cervical specimens. (Mount S, Harmon M, Eltabbakh G, Uyar D, Leiman G) Acta Cytol 2004;48(3):363-71       18 Citations
1Lymph node control in cervical cancer. (Grigsby PW, Singh AK, Siegel BA, Dehdashti F, Rader J, Zoberi I) Int J Radiat Oncol Biol Phys 2004 Jul 01;59(3):706-12       97 Citations
1Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. (Lentz SE, Muderspach LI, Felix JC, Ye W, Groshen S, Amezcua CA) Obstet Gynecol 2004 Jun;103(6):1204-10       88 Citations
1Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. (Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I) J Clin Oncol 2004 Jun 01;22(11):2167-71       211 Citations
1Double cervix with bilateral and synchronous HSIL associated with different high-risk HPV types. A case report. (Pinto KR, Lu DW, Rader JS, Dávila RM) Acta Cytol 2004;48(2):273-7       6 Citations
1The sculpted pear: An unfinished brachytherapy tale. (Erickson BA) Brachytherapy 2003;2(4):189-99       18 Citations
2CT-guided high-dose-rate dose prescription for cervical carcinoma: the importance of uterine wall thickness. (Mai J, Rownd J, Erickson B) Brachytherapy 2002;1(1):27-35       16 Citations
1Denaturing high-performance liquid chromatography for detecting and typing genital human papillomavirus. (Li J, Gerhard DS, Zhang Z, Huettner PC, Wright J, Nguyen L, Lu D, Rader JS) J Clin Microbiol 2003 Dec;41(12):5563-71       12 Citations
1A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. (Armstrong DK, Blessing JA, Rader J, Sorosky JI, Gynecologic Oncology Group Study) Invest New Drugs 2003 Nov;21(4):453-7       20 Citations
1Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies. (Wright JD, Herzog TJ, Mutch DG, Gibb RK, Rader JS, Davila RM, Cohn DE) Gynecol Oncol 2003 Oct;91(1):134-8       15 Citations
1A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. (Gerhard DS, Nguyen LT, Zhang ZY, Borecki IB, Coleman BI, Rader JS) Gynecol Oncol 2003 Sep;90(3):560-5       37 Citations
1Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. (Uyar DS, Eltabbakh GH, Mount SL) Gynecol Oncol 2003 May;89(2):227-32       25 Citations
1Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. (Lonky NM, Felix JC, Naidu YM, Wolde-Tsadik G) Obstet Gynecol 2003 Mar;101(3):481-9       58 Citations
1The science behind the effectiveness of in vivo screening. (Felix JC) Am J Obstet Gynecol 2003 Mar;188(3 Suppl):S8-12       9 Citations
1In vitro adjuncts to the pap smear. (Felix JC, Amezcua C) Obstet Gynecol Clin North Am 2002 Dec;29(4):685-99, vii       5 Citations
1A stiff bristled, spiral-shaped ectocervical brush: a device for transepithelial tissue biopsy. (Monk BJ, Cogan M, Felix JC, Lonky NM, Bentz JS, Marshall CJ, Cestero RM, Rowe LR, Lonky SA) Obstet Gynecol 2002 Dec;100(6):1276-84       5 Citations
1Aberrant expression of E-cadherin in cervical intraepithelial neoplasia correlates with a false-negative Papanicolaou smear. (Felix JC, Lonky NM, Tamura K, Yu KJ, Naidu Y, Lai CR, Lonky SA) Am J Obstet Gynecol 2002 Jun;186(6):1308-14       27 Citations
1Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. (Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J) J Clin Oncol 2002 Apr 01;20(7):1832-7       124 Citations
1Clinical implications of human papillomavirus infection. (Sisk EA, Robertson ES) Front Biosci 2002 Mar 01;7:e77-84       20 Citations
1The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Chao C, Erickson B, Fowler J, Gupta N, Martinez A, Thomadsen B, American Brachytherapy Society) Int J Radiat Oncol Biol Phys 2002 Jan 01;52(1):33-48       127 Citations
2Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer. (Mai J, Erickson B, Rownd J, Gillin M) Int J Radiat Oncol Biol Phys 2001 Nov 15;51(4):1131-41       30 Citations
4In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma. (Allen JR, Prost RW, Griffith OW, Erickson SJ, Erickson BA) Am J Clin Oncol 2001 Oct;24(5):522-9       48 Citations
1Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix. (O'sullivan MJ, Rader JS, Gerhard DS, Li Y, Trinkaus KM, Gersell DJ, Huettner PC) Hum Pathol 2001 May;32(5):475-8       17 Citations
1Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry. (Decker WE, Erickson B, Albano K, Gillin M) Int J Radiat Oncol Biol Phys 2001 Jun 01;50(2):561-7       18 Citations
1Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. (Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F) Oncogene 2001 Mar 22;20(12):1509-18       374 Citations
1Cyclooxygenase-2 is overexpressed in human cervical cancer. (Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ) Clin Cancer Res 2001 Feb;7(2):429-34       321 Citations
1Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. (Grigsby PW, Perez CA, Chao KS, Herzog T, Mutch DG, Rader J) Int J Radiat Oncol Biol Phys 2001 Mar 01;49(3):733-8       63 Citations
1Radical hysterectomy for cervical cancer in obese women. (Cohn DE, Swisher EM, Herzog TJ, Rader JS, Mutch DG) Obstet Gynecol 2000 Nov;96(5 Pt 1):727-31       21 Citations
1The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D) Int J Radiat Oncol Biol Phys 2000 Aug 01;48(1):201-11       444 Citations
1Clinical significance of the qualification of atypical squamous cells of undetermined significance: An analysis on the basis of histologic diagnoses. (Vlahos NP, Dragisic KG, Wallach EE, Burroughs FH, Fluck S, Rosenthal DL) Am J Obstet Gynecol 2000 Apr;182(4):885-90       6 Citations
1Cervical cancer suppressor gene is within 1 cM on 6p23. (Rader JS, Li Y, Huettner PC, Xu Z, Gerhard DS) Genes Chromosomes Cancer 2000 Apr;27(4):373-9       12 Citations
1Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group. (Schilder RJ, Blessing JA, Morgan M, Mangan CE, Rader JS) Gynecol Oncol 2000 Feb;76(2):204-7       86 Citations
1Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls. (Neuman RJ, Huettner PC, Li L, Mardis ER, Duffy BF, Wilson RK, Rader JS) Obstet Gynecol 2000 Jan;95(1):134-40       24 Citations
1A single-visit cervical carcinoma prevention program offered at an inner city church: A pilot project. (Holschneider CH, Felix JC, Satmary W, Johnson MT, Sandweiss LM, Montz FJ) Cancer 1999 Dec 15;86(12):2659-67       32 Citations
1Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery. (Grigsby PW, Perez CA, Chao KS, Elbendary A, Herzog TJ, Rader JS, Mutch DG) Int J Radiat Oncol Biol Phys 1999 Oct 01;45(3):645-51       23 Citations
1The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result. (Fox J, Remington P, Layde P, Klein G) Am J Obstet Gynecol 1999 May;180(5):1104-9       35 Citations
1The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States. (Nag S, Orton C, Young D, Erickson B) Gynecol Oncol 1999 Apr;73(1):111-8       81 Citations
1Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study. (Duggan BD, Felix JC, Muderspach LI, Gebhardt JA, Groshen S, Morrow CP, Roman LD) Am J Obstet Gynecol 1999 Feb;180(2 Pt 1):276-82       112 Citations
1Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p. (Rader JS, Gerhard DS, O'Sullivan MJ, Li Y, Li L, Liapis H, Huettner PC) Genes Chromosomes Cancer 1998 May;22(1):57-65       49 Citations
1Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. (Roman LD, Felix JC, Muderspach LI, Varkey T, Burnett AF, Qian D, Morrow CP) Gynecol Oncol 1998 Mar;68(3):220-5       83 Citations
1Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features. (Huettner PC, Gerhard DS, Li L, Gersell DJ, Dunnigan K, Kamarasova T, Rader JS) Hum Pathol 1998 Apr;29(4):364-70       38 Citations
1Interstitial implantation of gynecologic malignancies. (Erickson B, Gillin MT) J Surg Oncol 1997 Dec;66(4):285-95       37 Citations
1Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. (Roman LD, Felix JC, Muderspach LI, Agahjanian A, Qian D, Morrow CP) Obstet Gynecol 1997 Nov;90(5):759-64       65 Citations
1Clinical indications for brachytherapy. (Erickson B, Wilson JF) J Surg Oncol 1997 Jul;65(3):218-27       19 Citations
1Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. (Muderspach LI, Curtin JP, Roman LD, Gebhardt JA, Klement V, Qian D, Morrow CP, Felix JC, Formenti SC, Muggia FM) Gynecol Oncol 1997 May;65(2):336-42       45 Citations
1Allelotyping of all chromosomal arms in invasive cervical cancer. (Rader JS, Kamarasova T, Huettner PC, Li L, Li Y, Gerhard DS) Oncogene 1996 Dec 19;13(12):2737-41       90 Citations
1Human papillomavirus testing in primary cervical screening. (Sun XW, Koulos JP, Felix JC, Ferenczy A, Richart RM, Park TW, Wright TO Jr) Lancet 1995 Sep 02;346(8975):636       3 Citations
1Potential of cervical electrosurgical excision procedure for diagnosis and treatment of cervical intraepithelial neoplasia. (Herzog TJ, Williams S, Adler LM, Rader JS, Kubiniec RT, Camel HM, Mutch DG) Gynecol Oncol 1995 Jun;57(3):286-93       31 Citations
1Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. (Udvadia AJ, Templeton DJ, Horowitz JM) Proc Natl Acad Sci U S A 1995 Apr 25;92(9):3953-7       200 Citations
1Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. (Arthur D, Kaufman N, Schmidt-Ullrich R, Kavanagh B, Simpson P, Hill M, Ali M) Int J Radiat Oncol Biol Phys 1995 Feb 15;31(4):743-51       15 Citations
1Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. (Kurzrock R, Ku S, Talpaz M) Cancer 1995 Jan 15;75(2):584-90       58 Citations
1The significance of positive margins in loop electrosurgical cone biopsies. (Felix JC, Muderspach LI, Duggan BD, Roman LD) Obstet Gynecol 1994 Dec;84(6):996-1000       118 Citations
1In situ localization of parathyroid hormone-like protein and mRNA in intraepithelial neoplasia and invasive carcinoma of the uterine cervix. (Liapis H, Crouch EC, Roby J, Rader JS) Hum Pathol 1993 Oct;24(10):1058-66       11 Citations
1Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience. (Rader JS, Haraf DJ, Halpern HJ, Rotmensch J, Spelbring DR, Sutton H, Javaheri G, Weichselbaum RR) J Surg Oncol 1990 Jul;44(3):157-65       14 Citations
1In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions. (Rader JS, Golub TR, Hudson JB, Patel D, Bedell MA, Laimins LA) Oncogene 1990 Apr;5(4):571-6       56 Citations
1Smoking and cervical cancer: cause or coincidence? (Layde PM) JAMA 1989 Mar 17;261(11):1631-3       29 Citations
1Carcinoma of the cervix and smoking. (Layde PM, Broste SK) Biomed Pharmacother 1989;43(3):161-5       13 Citations
1Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix. (Trevathan E, Layde P, Webster LA, Adams JB, Benigno BB, Ory H) JAMA 1983 Jul 22-29;250(4):499-502       114 Citations